Insider Trading May 7, 2026 04:32 PM

Aflac Director Executes Planned Stock Sale Amid Mixed Quarterly Earnings

Miwako Hosoda liquidates a portion of holdings via 10b5-1 plan as Aflac reports revenue beat alongside earnings miss.

By Nina Shah AFL

Aflac Inc (NASDAQ: AFL) director Miwako Hosoda has completed a sale of company stock, part of a pre-arranged trading strategy. This transaction occurs against a backdrop of recent financial disclosures from the insurance provider, which highlighted both top-line growth and a shortfall in earnings per share for the first quarter of 2026.

Aflac Director Executes Planned Stock Sale Amid Mixed Quarterly Earnings
AFL

Key Points

  • Miwako Hosoda executed a scheduled sale of 243 shares via a Rule 10b5-1 plan at $114.50 per share.
  • Aflac reported a revenue beat of $4.35 billion against a $4.18 billion forecast, though adjusted EPS of $1.75 missed the $1.80 target.
  • The company is expanding its administrative footprint with a new office in Maine to manage state-level medical leave programs.

Insider Transaction Details

On May 6, 2026, Miwako Hosoda, serving as a director for Aflac Inc (NASDAQ: AFL), sold 243 shares of the company's common stock. The transaction was executed at a price per share of $114.50, resulting in a total sale value of $27,823. This divestment was not an ad hoc decision but was conducted pursuant to a Rule 10b5-1 trading plan that Ms. Hosoda had previously adopted on December 1, 2025.

Following the completion of this trade, Ms. Hosoda maintains a direct holding of 7,743 shares of Aflac common stock. As of the current reporting period, Aflac Inc carries a market capitalization of $57.8 billion and is trading at a P/E ratio of 12.9.


Financial Performance and Corporate Governance

The recent insider activity follows Aflac's release of its first-quarter 2026 earnings, which presented a nuanced financial picture. While the company reported revenue of $4.35 billion, surpassing the anticipated $4.18 billion, its adjusted earnings per share (EPS) stood at $1.75. This figure was lower than the $1.80 forecasted by analysts.

On the governance front, Aflac recently held its annual meeting where shareholders approved nearly all presented proposals. The board successfully elected 11 directors and ratified KPMG LLP as the independent registered public accounting firm through 2026. One notable exception to shareholder approval was a specific measure regarding the appointment of an independent board chairman, which did not pass.

In terms of operational expansion, Aflac has established a new office in South Portland, Maine. This facility is tasked with the administration of the state's Paid Family and Medical Leave program, a role that involves managing claims for more than 500,000 eligible workers and participating employers.


Market Context and Key Observations

Aflac continues to demonstrate long-term dividend consistency, having increased its dividend for 42 consecutive years. The current dividend yield stands at 2.15%. While the company's recent earnings results showed a discrepancy between revenue growth and EPS achievement, the stock is currently viewed by some valuation models as undervalued.

Risks

  • Earnings volatility: The disparity between revenue beats and EPS misses highlights potential pressure on profitability margins within the insurance sector.
  • Governance shifts: While most proposals passed, the rejection of a shareholder measure for an independent board chairman suggests ongoing discussions regarding corporate structure.

More from Insider Trading

Phillips 66 Director Increases Stake via Recent Common Stock Acquisition May 7, 2026 Expand Energy Executive Increases Stake Amid Recent Financial Performance and Leadership Shifts May 7, 2026 SLB Director Executes Share Sale Amid Recent Analyst Optimism May 7, 2026 Recursion Pharmaceuticals Director Executes $105,600 Stock Sale Amid Mixed Q1 Results May 7, 2026 Equinix Executive Chairman Charles J. Meyers Executes $5.67 Million Share Sale May 7, 2026